Clinical Trial Update: A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating LY3484356 in Chinese participants with advanced breast cancer is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• LY3484356

Snippet

Sponsor: Eli Lilly and Company | Conditions: Breast Neoplasms | Phase 1 | Status: ACTIVE_NOT_RECRUITING